A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients with Cystic Fibrosis
Clinical trial NCT03822455 · TERMINATED
Trial details
- NCT number
- NCT03822455
- Sponsor
- AlgiPharma AS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2020-03-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.